BIOPOA

Company

COMPANY

History

GLOBAL Biopharmaceutical development company

The path of passion that we’ve been walking

2005~2010

2005
09 Move into SNU College of Agriculture and Life Sciences Business Incubation Center
12 Preliminary venture business certification
2007
02 Establishment of BioPOA Co. Ltd./ CEO S. H. Cho
2008
01 Capital increase through in-kind investment of patented technology
01 Attracting investment from agricultural corporation “JoinBio”
11 Venture business certification
2009
01 Office expansion and relocation (Singal-dong)
08 Establishment of company-affiliated research center and designation of LMO research facility
2010
11 Designation of Pathological Diagnostic agency for animal disease from APQA (Animal and Plant Quarantine Agency)
GLOBAL Biopharmaceutical development company

We will create a better future for animal and human being.

2011~2020

2012
03 Establishment of Animal Experiment Ethics Committee
2015
03 Office expansion and relocation (384-62 Singal-dong)
2016
05 VC institutional investment attraction
2017
03 Investment attraction of Yuhan Corporation
2018
04 NEW Office building moving (Hwaseong City)
09 2nd Investment attraction of Yuhan Corporation
2020
05 Approved KVGMP : Biologicals
06 Clinical trial institution for animal health products
08 Selected as an IPO organizer
08 Achievement of manufacturing license for In vitro diagnostic medical device
08CE certification (COVID-19 diagnostic kit 'PoaCheck’)
08 Achievement of product license for COVID-19 PoaCheck
12 Attracting investment from KOREA THUMBVET CO., LTD. 12
GLOBAL Biopharmaceutical development company

Reverse genetics technology for the manufacturing PRRS virus vaccines

2021~Now

2021
01 First overseas export of COVID-19 diagnostic kit 'PoaCheck’ (Uzbekistan)
01 Remodeling of Vaccine factory
02 Approval of virus manufactory in Vaccine factory
04 Achievement of product license for PRRS live vaccines (“PoaVac”)
10 Approved KVGMP : Biologicals (Virus Vaccine)
11 Approval of national test “PoaVac-PRRS”
2022
03 Preliminary technology evaluation
(Nice D&B-Commercial Credit Bureau)
03 Designated as veterinary life resource management institution
07 “NeT” New technology certification [Reverse genetics SAVE(Synthetic Attenuated Virus Engineering) technology]